EUVIMEDEUVIMED entdecken
Crossref

Development of Drug Resistance in the Treatment of Systemic Candidiasis: New Challenges and Future Solutions

Abbas Ali Jafari Nodoushan

Advances in Pharmacology and Therapeutics Journal · 25.07.2026

DOI: 10.18502/aptj.v6i1.22110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacology and Therapeutics Journal, online erschienen am 25.07.2026. Verfasst von Abbas Ali Jafari Nodoushan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic candidiasis continues to be the most prevalent healthcare-associated invasive fungal infection, contributing significantly with a high mortality. While Candida albicans continues to be the predominant causative agent, other species such as C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, and various rare Candida species exhibit resistance to fluconazole and other triazole antifungals. The increasing prevalence of fluconazole-resistant C. parapsilosis, echinocandin-resistant C. glabrata, and a new reported multidrug-resistant species, Candida auris, has made clinical management more challenging. Effective antifungal treatment must be chosen based on patient-specific factors, the severity of the disease, history of antifungal use, local epidemiological data, organ involvement, the presence of indwelling medical devices, and accurate species identification. Currently, the challenges associated with antifungal treatments comprise the slow diagnosis reducing from traditional culture techniques and the restricted application of rapid diagnostic tools in clinical settings. To resolve these challenges, it is essential to develop innovative antifungal agents, improve stewardship programs, and enhance global resistance monitoring to maximize treatment results and maintain the effectiveness of antifungal therapies.

Zitieren

APA

Nodoushan, A. A. J. (2026). Development of Drug Resistance in the Treatment of Systemic Candidiasis: New Challenges and Future Solutions. Advances in Pharmacology and Therapeutics Journal. https://doi.org/10.18502/aptj.v6i1.22110

Vancouver

Nodoushan AAJ. Development of Drug Resistance in the Treatment of Systemic Candidiasis: New Challenges and Future Solutions. Advances in Pharmacology and Therapeutics Journal. 2026. doi:10.18502/aptj.v6i1.22110

BibTeX
@article{Nodoushan2026,
  author = {Nodoushan, Abbas Ali Jafari},
  title = {Development of Drug Resistance in the Treatment of Systemic Candidiasis: New Challenges and Future Solutions},
  journal = {Advances in Pharmacology and Therapeutics Journal},
  year = {2026},
  doi = {10.18502/aptj.v6i1.22110}
}
Kostenlos starten →